Atlas Trials

Enzalutamide and External Beam Hypofractionated Radiotherapy For Intermediate Risk Localized Prostate Cancer

Clinical trial NCT03196388 · UNKNOWN

Trial details

NCT number
NCT03196388
Sponsor
Fundación Canaria Instituto de Investigación Sanitaria de Canarias
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Carcinoma
Start date
2017-12-27
Primary completion
2018-06-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.